From the Journals

Study finds 19% of Merkel cell carcinomas are virus negative


 

FROM THE JOURNAL OF INVESTIGATIVE DERMATOLOGY

The National Institutes of Health, the Colin Johnston Fund, and the Janet Canning Fund supported the study. Dr. Moshiri reported having no relevant financial disclosures; one of his associates reported that her institute received research funding from Valeant and Pfizer unrelated to this work.

Pages

Recommended Reading

Amlodipine reduced vismodegib-induced muscle cramps
MDedge Hematology and Oncology
FDA approves hedgehog pathway inhibitor for locally advanced BCC
MDedge Hematology and Oncology
Ingenol mebutate helped clear actinic keratoses
MDedge Hematology and Oncology
EADV: Prophylactic photodynamic therapy benefits transplant recipients
MDedge Hematology and Oncology
Nonmelanoma skin cancer initially misdiagnosed in 36% of small cohort
MDedge Hematology and Oncology
EADV: Vismodegib treatment breaks don’t hurt efficacy
MDedge Hematology and Oncology
Sirolimus reduced posttransplant skin cancer risk
MDedge Hematology and Oncology
Organ transplant recipients face increased risk of BCC
MDedge Hematology and Oncology
Itraconazole targets basal cell carcinoma
MDedge Hematology and Oncology
Matrilin-2 protein distinguished BCCs from benign tumors in study
MDedge Hematology and Oncology